Speakers: Brad Peter Glick, DO, MPH, FAAD, FAOCD, FACOFP Dermatologist, Dermatologic Surgeon and Principal Investigator Larkin Health System – GSI Clinical Research Miami, Florida

Moderator: Leon Kircik, MD, FAAD Medical Director, International Dermatology Foundation Clinical Professor of Dermatology Icahn School of Medicine at Mount Sinai, New York, NY Indiana University Medical Center, Indianapolis, IN Medical Director Physicians Skin Care, PLLC, Louisville, KY DermResearch, PLLC, Louisville, KY Skin Sciences, PLLC, Louisville, KY

Please join us for our next IDF Educational Series Webinar: Choose Fast Relief From Hives and Itch With RHAPSIDO®: An Oral Targeted Treatment Approach for Uncontrolled Chronic Spontaneous Urticaria Despite Antihistamine Use This presentation will explore a different approach in patient care with RHAPSIDO by explaining the role of Bruton’s tyrosine kinase (BTK) in CSU pathophysiology and MOA of RHAPSIDO as the first-of-its-kind oral BTK inhibitor (BTKi) therapy, exploring clinical data on RHAPSIDO, including efficacy, safety, and onset of action, to support informed treatment decisions after antihistamines fall short, and providing real-world perspectives from expert peers on how RHAPSIDO may help your appropriate patients.

REGISTER